Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis

Christopher S. King, Aaron B. Holley, Jeffrey L. Jackson, Andrew F. Shorr, Lisa K. Moores*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis'. Together they form a unique fingerprint.

Medicine & Life Sciences